The medication is not suitable for patients with a personal or family history of medullary thyroid carcinoma (MTC), MEN 2 syndrome (multiple endocrine neoplasia type 2 syndrome), or pancreatitis
BPC 157s effect on healing, Journal of Physiology-Paris, Volume 91, Issues 35, MayOctober 1997, Pages 173-178 (5) Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ
Protocol adjustments Increasing dosing: If healing slower than expected or pain not improving after 4-6 weeks, consider increasing dose 25-50%
Supplier Verification : Working with established suppliers who provide comprehensive testing documentation and quality assurance
At the 0.25mg starting dose, a 5mg vial theoretically lasts 20 weeks